A prospective double-blind randomised controlled trial of the impact of remote-organ ischaemic preconditioning on perioperative myocardial morbidity and postoperative complications in head and neck surgery: Myocardial Event Reduction with Ischaemic-preconditioning Therapy (MERIT)

Imperial College Healthcare NHS Trust (UK)0 个研究点目标入组 92 人开始时间: 2010年7月29日最近更新: 2018年5月28日

适应症

试验速览

暂无简介。

•1. Patients aged under 90 years, either sex
•2. Squamous cell carcinoma of the upper aerodigestive tract (head and neck cancer)
•3. Undergoing excision of the primary site tumour and removal of cervical lymph nodes as part of the management of their condition

•1. Patients over 90 years of age
•2. Patients unable to give informed consent
•3. Patients unfit to undergo general anaesthesia
•4. Patients undergoing only neck dissection surgery
•5. Patients with non-squamous cell carcinoma pathology
•6. Patients undergoing excision of tumours of the skull base
•7. Diabetic patients taking sulphonylurea medications
•8. Patients taking nicorandil
•9. Patients undergoing trans-oral laser resection of tumours
•10. Patients with a previous history of deep-vein thrombosis or pulmonary embolism
•11. Patients with known peripheral vascular disease who have an Ankle-Brachial Pressure Index less than 0.7)

发起方

Imperial College Healthcare NHS Trust (UK)